Zyclara 3.75 % (Imiquimod CREAM) 3.75 %

ZYCLARA 3.75% cream is a topical medication containing imiquimod, used for dermatological conditions. This prescription treatment is designed for targeted application, offering a convenient solution for specific skin concerns.

Strength

3.75 %

Pack Size

28X250MG

Manufacturer / TM Owner

BAUSCH HEALTH, CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ZYCLARA 3.75% cream is primarily used for the treatment of certain skin conditions. It works by stimulating the immune system to help the body fight off infections or abnormal skin cells. This cream is often prescribed for conditions that require immune response activation, making it a key player in dermatological care.

Side Effects

When applied as directed, ZYCLARA 3.75% cream may cause localized skin reactions such as redness, itching, or swelling at the application site. These effects are generally mild and temporary, indicating the cream is actively working. Users should monitor their skin for any unusual reactions and consult their healthcare provider if concerns arise.

Precautions & Warnings

ZYCLARA 3.75% cream should be used exactly as prescribed by a healthcare professional. It is important to avoid applying the cream to broken or irritated skin. Keep the cream out of reach of children and store it at room temperature unless otherwise instructed. Always follow the usage guidelines provided by your healthcare provider.

Avoid Interactions

ZYCLARA 3.75% cream may interact with other topical medications or skin treatments. It is advisable to inform your healthcare provider about all medications you are currently using to avoid potential interactions. Avoid using the cream with other topical products unless directed by a healthcare professional.

References

Frequently Asked Questions

ZYCLARA 3.75% cream is used for the treatment of certain skin conditions by stimulating the immune system.

Apply ZYCLARA 3.75% cream as directed by your healthcare provider, typically to the affected area of the skin.

Common side effects may include redness, itching, or swelling at the application site.

It is advisable to consult your healthcare provider before using ZYCLARA 3.75% cream with other topical medications.

Store ZYCLARA 3.75% cream at room temperature, out of reach of children, unless otherwise instructed.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.